(Q80971779)
Statements
Capecitabine plus 3-weekly irinotecan (XELIRI regimen) as first-line chemotherapy for metastatic colorectal cancer: phase II trial results (English)
Yehuda Z Patt
James E Liebmann
Dimitrios Diamandidis
S Gail Eckhardt
Milind Javle
Glen R Justice
Wayne Keiser
Joseph R Salvatore
Alice Bexon